Allarity Therapeutics (ALLR) Payables (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Payables came in at $5.7 million in Q1 2026, down 1.03% YoY from $5.7 million in Q1 2025, and down 0.55% on a QoQ basis from $5.7 million in Q4 2025.
Allarity Therapeutics (ALLR) Payables (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Payables data on file, last reported at $5.7 million in Q1 2026.
- Quarterly Payables fell 1.03% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 million (down 1.03% YoY) and the FY2025 annual result came in at $5.7 million, up 35.84% from the prior year.
- Payables fell to $5.7 million in Q1 2026, from $5.7 million in the prior quarter.
- In the past five years, Payables ranged from a high of $13.7 million in Q1 2024 to a low of $4.2 million in Q4 2024.
- A 5-year average of $7.4 million and a median of $6.6 million in 2022 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables surged 714.52% — and 2025, when it plunged 58.39%.
- Tracing ALLR's Payables over 5 years: stood at $6.6 million in 2022, then soared by 46.66% to $9.7 million in 2023, then sank by 56.95% to $4.2 million in 2024, then soared by 35.84% to $5.7 million in 2025, then fell by 0.55% to $5.7 million in 2026.
- The last three Payables figures came in at $5.7 million (Q1 2026), $5.7 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - | 35.57 Mn |
| 10 | Allarity Therapeutics | 22.39 Mn | 22.39 Mn | - | 24.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.65 Mn |
| Dec 31, 2025 | 5.68 Mn |
| Sep 30, 2025 | 4.60 Mn |
| Jun 30, 2025 | 4.61 Mn |
| Mar 31, 2025 | 5.71 Mn |
| Dec 31, 2024 | 4.18 Mn |
| Sep 30, 2024 | 4.70 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | 13.72 Mn |
| Dec 31, 2023 | 9.72 Mn |
| Sep 30, 2023 | 10.29 Mn |
| Jun 30, 2023 | 9.23 Mn |
| Mar 31, 2023 | 6.45 Mn |
| Dec 31, 2022 | 6.63 Mn |
| Sep 30, 2022 | 7.80 Mn |
| Jun 30, 2022 | 8.44 Mn |
| Mar 31, 2022 | 8.97 Mn |
| Dec 31, 2021 | 11.97 Mn |
| Sep 30, 2021 | 957,000.00 |
| Dec 31, 2020 | 2.16 Mn |